2024/1685

18.6.2024

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1685

of 17 June 2024

concerning the authorisation of a preparation of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract as a feed additive for dairy cows

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1), and in particular Article 9(2) thereof,

Whereas:

(1) Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such an authorisation.

(2) In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of a preparation of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract. That application was accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003.

(3) The application concerns the authorisation of a preparation of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract as a feed additive for dairy cows and other dairy ruminants, requesting that additive to be classified in the category ‘nutritional additives’ and in the functional group ‘vitamins, pro-vitamins and chemically well-defined substances having similar effect’. The preparation is intended to be used only in a complementary feed consisting of an encapsulated, controlled-release bolus to reduce the risk of milk fever and subclinical hypocalcaemia.

(4) The European Food Safety Authority (‘the Authority’) concluded in its opinion of 29 June 2022 (2) that the preparation of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract, as applied in the animal studies evaluated, is safe for dairy cows when administered orally in a bolus containing 500 μg of 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract once during the pre-parturient period (from 9 days before calving to immediately before calving). In the animal studies evaluated, the bolus was complemented by a feed containing appropriate levels of calcium and magnesium. Owing to a lack of data, the Authority was neither in the position to conclude on the safety of the subsequent administration of a second bolus as recommended by the applicant, if the cow has not calved within 9 days after bolus administration, nor on the safety for use in dairy ruminants other than cows (

Bos taurus

). It further concluded that the preparation is safe for consumers and the environment and that it is not irritating to skin and eyes and it is not a sensitiser. It considered that exposure via inhalation is unlikely when used in a bolus. The Authority concluded that the administration of the additive in a bolus containing 500 μg of 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract in a period from 9 days before calving to immediately before calving has the potential to prevent hypocalcaemia in dairy cows when applied as in the animal studies evaluated. The Authority does not consider that there is a need for specific requirements of post-market monitoring. It also verified the report on the method of analysis of the feed additive in feed submitted by the Reference Laboratory set up by Regulation (EC) No 1831/2003.

(5) Subsequently, the applicant withdrew the application for authorisation of the preparation of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract for all dairy ruminants except for dairy cows.

(6) The Commission considers that the active substance of the feed additive is the glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract. The feed additive consists of a preparation containing the active substance that is stabilised with maltodextrin or other suitable carriers. The preparation is subsequently to be incorporated in a bolus that is regarded as a complementary feed.

(7) The assessment of the preparation of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that preparation should be authorised for the sole use in a complementary feed in the form of a bolus.

(8) In addition, for safety reasons, the Commission considers that the maximum release level of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract released from the bolus in the body of the animals should be indicated as maximum content in the complete feed. Taking into account that glycosylated 1,25-dihydroxycholecalciferol is a precursor of 25-hydroxycholecalciferol and that the Authority stated in its opinion of 5 July 2023 (3) concerning 25-hydroxycholecalciferol produced with

Saccharomyces cerevisiae

CBS 146008 that no conclusion on the potential of that substance to be a skin sensitiser or on its effects on the respiratory system could be reached due to absence of data, the Commission considers that appropriate breathing and skin protective measures should be taken to prevent adverse effects on the health of the users of the additive, when handling the substance in view of the incorporation in a bolus. Furthermore, the Commission considers that as 25-hydroxycholecalciferol depresses the activity of 1α-hydroxylase in the kidney, the simultaneous use of glycosylated 1,25-dihydroxycholecalciferol from

Solanum glaucophyllum

extract with that additive should not be allowed.

(9) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Authorisation

The preparation specified in the Annex, belonging to the additive category ‘nutritional additives’ and to the functional group ‘vitamins, pro-vitamins and chemically well-defined substances having similar effect’, is authorised as an additive in animal nutrition, subject to the conditions laid down in that Annex.

Article 2

Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the

Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 17 June 2024.

For the Commission

The President

Ursula VON DER LEYEN

(1)

OJ L 268, 18.10.2003, p. 29

, ELI:

http://data.europa.eu/eli/reg/2003/1831/oj

(2)

EFSA Journal

2022;20(8):7434.

(3)

EFSA Journal

2023;21(8):8168.

ANNEX

Identification number of the feed additive

Additive

Composition, chemical formula, description, analytical method

Species or category of animal

Maximum age

Minimum content

Maximum content

Other provisions

End of period of authorisation

mg of 1,25-dihydroxycholecalciferol/kg of complete feedingstuff

with a moisture content of 12 %

Category of nutritional additives. Functional group: vitamins, pro-vitamins and chemically well-defined substances having similar effect. Subclassification: Vitamin D

3a673

Glycosylated 1,25-dihydroxycholecalciferol from Solanum glaucophylum extract

Additive composition

Preparation of Solanum glaucophylum extract with a minimum of 0,005 % of glycosylated 1,25- dihydroxycholecalciferol

Solid form

Characterisation of active substance

Glycosylated 1,25-dihydroxycholecalciferol

Chemical formula: C27H44O3-×(C6H10O5)n, where n = 1 to 12

CAS number: 89457-77-2

Produced by ethanolic extraction of leaves of Solanum glaucophyllum

Analytical method (1)

—	For the quantification of glycosylated 1,25-dihydroxycholecalciferol in the feed additive and in the complementary feed (bolus):

—	Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).

Dairy cows

—

0,004

1.	The additive shall be only used for incorporation in a complementary feed (in the form of a bolus) to reduce the risk of milk fever and subclinical hypocalcaemia.

2.	The use of the additive shall be allowed only once during the pre-parturient period (from 9 days before calving to immediately before calving).

The additive shall be orally administered once in the form of a bolus, with daily administration of:

—	a minimum of calcium of 60 g per cow during one week before calving and 84 g per cow until the end of the third week of lactation,

—	a minimum of magnesium of 18 g per cow during one week before calving and 26 g per cow until the end of the third week of lactation.

4.	The directions for use of the additive shall indicate the storage conditions.

5.	Maximum content of the combination of glycosylated 1,25-dihydroxycholecalciferol with vitamin D3 (cholecalciferol) per kg of complete feed: 0,1 mg(2) of cholecalciferol.

6.	Simultaneous use of the additive with 25-hydroxycholecalciferol shall not be permitted.

For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address the potential risks resulting from their use. Where those risks cannot be eliminated by such procedures and measures, the additive and premixtures shall be used with personal breathing and skin protective equipment.

8 July 2034

(1) Details of the analytical methods are available at the following address of the Reference Laboratory:

https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports

(2) 40 IU cholecalciferol (vitamin D3) = 0,001 mg cholecalciferol (vitamin D3).

ELI: http://data.europa.eu/eli/reg_impl/2024/1685/oj

ISSN 1977-0677 (electronic edition)